OBJECTIVES: Our goal was to assess the results after orthotopic branched endovascular aortic arch repair using a new double-branch endoprosthesis in patients with thoracic aortic disease affecting the aortic arch who cannot undergo classical surgery.
INTRODUCTION
The variety of options for the treatment of patients with thoracic aortic disease involving the aortic arch has broadened in the last decade [1] [2] [3] . Supra-aortic transpositions of various extents have proven to be a safe and durable approach, except for total arch rerouting, which is associated with a high rate of retrograde Type A aortic dissection [4, 5] . Additionally, the classical surgical procedure has developed impressively, and the frozen elephant trunk (FET) procedure has emerged as an excellent therapeutic approach in patients with extensive thoracic aortic disease, enabling both endovascular and surgical secondary distal extension [6, 7] . However, a group of patients remain in whom neither supraaortic transpositions and thoracic endovascular aortic repair (TEVAR) nor the FET procedure are approaches of first choice due to patient frailty and other obviating factors.
The aim of this study was to assess results after orthotopic branched endovascular aortic arch repair using a new doublebranch (DB) endoprosthesis in patients with thoracic aortic disease affecting the aortic arch who cannot undergo classical surgery.
PATIENTS AND METHODS

Patients
Within a 4-year period, 15 patients with thoracic aortic disease affecting the aortic arch were treated with the Bolton Relay Plus DB endoprosthesis in 4 centres. Chronic health conditions, risk factors and underlying aortic diseases are presented in Table 1 . The average aneurysm size was 6.3 cm. Two patients had post-dissection aneurysmal formation. No patients had had previous surgery for acute Type A aortic dissection. In 1 patient who had had elective aortic root and ascending aortic replacement, the ascending prosthesis was used as a proximal landing zone. Risk stratification was performed using both logistic EuroSCORE I and II calculations. Neurological injury was stratified according to the Valve Academic Research Consortium criteria [8] . This study was not funded by industry.
Decision-making algorithm
Patients with connective tissue disease are generally excluded from this approach. The general decision-making algorithm was similar in all 4 centres. Patients are referred to the aortic outpatient clinic, and computed tomography angiographic scans of the entire aorta form the basis for decision-making in all cases. If a sufficient proximal landing zone (i.e. at least 2.5 cm) can be gained by either subclavian-to-carotid or by double transposition, then 1 of these 2 options is performed, followed by TEVAR to treat the underlying disease. If the extent of the disease is more proximal, patients are either considered for the FET operation with or without secondary distal TEVAR extension. If the patient is too frail or there are other obviating factors, a procedure with a DB endoprosthesis is considered. Figure 1 shows a classical example of an 83-year-old patient in whom the proximal landing zone with double transposition would have been merely 1.8 cm. Because the patient had a severely reduced left ventricular ejection fraction, an FET approach was deemed not the best option.
In the first author's institution, each patient with aortic arch disease is evaluated for the feasibility of this approach in order to gain experience in developing an anatomical selection algorithm. Finally, 1 out of 10 patients remains anatomically eligible. The main reason for rejecting a patient for this approach is that the requirements for the length of the ascending aorta (particularly in patients with previous ascending aortic replacement because the requested length of the ascending graft is 6.5 cm) and for the diameter of the left common carotid artery (LCCA) are rarely met because both the company and the physicians are reluctant to compromise the remaining effective orifice area of the LCCA by both the fabric and the nitinol skeleton. There is no general recommendation regarding angulations. However, from clinical experience in classical TEVAR, aortic arch angulations of more than 90 are associated with an increased probability of Type IIIb endoleakage, meaning that, with the acute angulation of the graft, a nitinol crown caudal to the site of the acute angulation may perforate the fabric cranial to this site.
Anatomical prerequisites
The anatomical prerequisites for the DB endoprosthesis approach are (i) an ascending aortic diameter of less than 40 mm, (ii) a centre-lined length of the ascending aorta from the sinotubular junction to the offspring of the brachiocephalic trunk of at least 6.5 cm and (iii) regular diameters of the brachiocephalic trunk and the LCCA where the minimum diameter of the LCCA is 7 mm for insertion of the supra-aortic extension. The approach is discouraged in patients with remaining dissection of the supra-aortic vessels after previous Type A repair. Currently, all devices are custom-made.
Finally, the size of the window for the supra-aortic branches is 5 cm in length, meaning that the distance from the brachiocephalic trunk offspring to the end of the LCCA has to be < _5 cm, which occurs frequently. To the authors' knowledge, no surgeon refused to do the procedure if the distance between the vessels exceeded 5 cm.
Prosthetic design
The Bolton Relay Plus DB endoprosthesis is designed as a modular system with retrograde delivery of the main body from the Categorical data are n (%); continuous data are median (1st quartile; 3rd quartile). femoral or iliac axis. The main body (Fig. 2) has a large window hosting 2 internal tunnels for secondary connection of the supraaortic extensions to the brachiocephalic trunk (posterior tunnel) and to the LCCA (anterior tunnel). These extensions are essentially modified iliac limbs of the Bolton abdominal endovascular aneurysm repair system (Treo). Before the availability of these extensions, alternatives was used. Recommended oversizing for this kind of procedure is 15% at each landing zone (ascending aorta, brachiocephalic trunk, LCCA and descending aorta). The exception are patients with post-dissection aneurysmal formation for whom distal sizing is done according to the diameter of the true lumen as well as to institutional standards. The introduction system of the device has a so-called selfalignment mechanism, meaning that during insertion the precurved tip of the introduction system aligns itself with the aortic arch as needed. The window for the supra-aortic branches is mounted such that it automatically aligns with the outer curvature. Radiopaque markers indicate where to begin and the orientation of the window. Fusion imaging was not routinely used in this setting. The main reason is that insertion of a stiff guidewire has the potential to substantially alter the geometry of the arch and the supra-aortic branches, which might be misleading when identifying the offspring of the supra-aortic branches.
The introduction system for the main body of the device is 25 Fr, which requires a minimum access vessel diameter of 8-9 mm; the supra-aortic extensions have a 14-Fr profile.
Procedural algorithm
Initially, the left subclavian artery (LSA) is revascularized according to the preference of the operating physician. The intention of routine revascularization refers to the maintenance of inflow to the left vertebral artery for the cerebellar as well as the spinal cord blood supply in order to reduce to a minimum the remaining risk for stroke or symptomatic spinal cord ischaemia. Alternatively, adequate diagnostics are performed in advance to reconfirm non-dominance of the left vertebral artery, and intentional overstenting without revascularization is performed.
As the initial endovascular step, the main body of the prosthesis is inserted. After correct orientation of the window to the supra-aortic branches, the main body is deployed under hypotensive conditions induced by rapid pacing. The nose cone passes the aortic valve for correct positioning, which usually does not interfere with aortic valve function. After deployment, full antegrade supra-aortic flow is preserved via both internal tunnels. The first modified iliac limb is inserted via the right common carotid artery (or via the right subclavian artery according to individual preference but via surgical cutdown in both scenarios) and is connected to the posterior tunnel. Correct cannulation of the tunnel is confirmed by temporarily inflating a contrast-filled balloon. The same manoeuvre is carried out via the LCCA. If needed, a TEVAR extension to downstream aortic segments is then performed. Balloon dilation of the connections between the grafts or at the landing zones is not routinely performed. Cerebrospinal fluid drainage is routinely performed when a distal TEVAR extension is warranted. Neuromonitoring by motor evoked potentials and somatosensory evoked potentials is done on a case-by-case basis. Figure 3 shows a completion computed tomography scan before discharge after orthotopic branched endovascular aortic arch repair. Because the aortic arch and the supra-aortic branches are high-flow areas, 100 mg of aspirin daily is recommended as a stand-alone therapy. Dual antiplatelet therapy is not routinely used.
Statistical methods
Continuous data are presented as the median and interquartile range (range from the 25th to the 75th percentile). Discrete data are given as counts and percentages.
RESULTS
In-hospital mortality rate and neurological injury
The overall in-hospital mortality rate was 6.7% (1 patient). This patient did not wake up after a perioperative myocardial infarction and disabling stroke and died 2 weeks after the procedure. Non-disabling strokes occurred in 2 (13.3%) patients. The reasons for the strokes may have been a heavily calcified ascending aorta as well as calcified supra-aortic vessels. Symptomatic spinal cord injury was not observed. The median fluoroscopy time was 38 ± 37 min; the median amount of contrast volume used was 167 ml ± 47 ml. No substantial worsening of renal function was observed.
Need for rerouting procedures and extent of disease
Ten patients received LSA revascularization before implantation of the DB endoprosthesis. Two patients had already undergone LSA revascularization and TEVAR previously and needed DB endoprosthesis repair due to the formation of a Type Ia endoleak. Three patients received adequate diagnostic tests in advance to reconfirm non-dominance of the left vertebral artery. Table 2 shows the extent of the disease.
Type I and III endoleaks and the need for reinterventions
A single Type Ib endoleak was observed that resolved spontaneously.
Follow-up and need for secondary interventions
The median follow-up period was 263 (1st quartile 84; 3rd quartile 564) days. One patient developed a Type II endoleak via the LSA and underwent successful embolization. Because the follow-up period is still short, no relevant aneurysmal sac shrinkage or expansion was observed.
Survival and aortic-related survival
Four patients died during the follow-up period. Causes of death were non-aorta-related in all cases. Aortic-related survival was 100%. Table 3 depicts outcome characteristics of the cohort.
DISCUSSION
Orthotopic branched endovascular aortic arch repair using the Bolton Relay Plus DB endoprosthesis is a safe and feasible technique that enriches the armamentarium for treating patients with thoracic aortic disease who cannot undergo classical surgery. Aortic-related survival is excellent, and the occurrence of disabling strokes and endoleaks warranting treatment is low. Further studies are needed to assess the long-term durability of this new method.
The observed mortality rate in this series was low and compares favourably to those in other reported series, both by classical surgery and by other total endovascular approaches using a similar concept with inner branches [7, 9] . However, the concept presented here is not meant to replace other approaches such as classical aortic arch surgery with or without the FET approach. Categorical data are n (%); continuous data are median (1st quartile; 3rd quartile). 14 (9; 18) In-hospital mortality rate 1 (7) Disabling stroke 1 (7) Aortic-related deaths during the follow-up period 0 All-cause deaths at follow-up 4 (27) Categorical data are n (%), continuous data are median (1st quartile; 3rd quartile).
There is overwhelming evidence that thoracic aortic surgery involving the aortic arch is a safe, highly efficient procedure with low perioperative morbidity and mortality in the elective setting as well as in emergencies-predominantly acute Type A aortic dissection-as long as they are uncomplicated, that is, without irreversible organ malperfusion, be it cerebral or visceral [1, 10] . Perioperative disabling and non-disabling strokes occurred in 7% and 13%, respectively. Our goal is to reduce neurological injury, predominantly cerebral, to a minimum in both approaches: in classical surgery as well as in any kind of endovascular intervention at the level of the aortic arch, but there is still work to do. Modified perfusion protocols, the routine implementation of selective antegrade cerebral perfusion and the move to a warmer hypothermic circulatory arrest temperature have substantially aided in optimizing outcomes in patients having classical surgery. In endovascular intervention, the main issues are the selection process, with the focus on understanding the underlying aortic disease, the goal being to achieve a minimum of manipulation within the aortic arch and within the supra-aortic vessels [11, 12] . The ability to select and individually address the underlying disease may well account for the excellent results of a recently published series using another inner branched endograft [9] .
Preserving supra-aortic flow via the LSA is a major adjunct in keeping the remaining risk of symptomatic spinal cord injury to a minimum [13, 14] . The conceptual approach of how to revascularize the LSA is at the discretion of the individual physician. However, based on our personal experience, we prefer bypass over transposition (which is inverse to our strategy in isolated LSA revascularization) because the offspring of an LSA bypass can be chosen at a high level of the native LCCA, thereby avoiding the necessity to pass the anastomosis when later inserting the supra-aortic extension to the LCCA.
It has been well established that there is a clear correlation between the length of the landing zone and the presence or absence of endoleaks and thereby the long-term failure or success [2, 15] . Because the entire ascending aorta (native or after previous replacement) may serve as a landing zone using the DB endoprosthesis, the remaining probability of a Type Ia endoleak is low. However, other issues should be kept in mind, such as the fact that the underlying disease (Type B aortic dissection) and the ascending aortic size (>40 mm) are associated with the occurrence of retrograde Type A aortic dissection when landing in Zone 0 [4, 16] . Also, landing in the brachiocephalic trunk as well as in the LCCA with additional stent grafts warrants a new approach to the entire issue because there are no established recommendations regarding the length of the landing zones in supra-aortic branches. Furthermore, in the case of the occurrence of an endoleak, the classifications of these endoleaks should be defined. The length of the branch-related landing zone might be seen as similar to that of the iliac axis, where 2 cm remain the recommendation of choice. With regard to the classification of endoleaks, a Type Ib scenario potentially best describes the mechanism induced by supra-aortic remaining or recurring perfusion of the arch disease.
There should be a thorough discussion of which diseases qualify best and which ones are presumably less ideal for the DB endoprosthesis approach at this early stage. In the authors' opinion, the distal arch diseases are the most ideal because supra-aortic rerouting will not be able to create a sufficiently long landing zone for treating mostly aneurysms or penetrating atherosclerotic ulcers, assuming that the supra-aortic branches are not affected by an obliterative load of underlying disease. An obliterative load of supra-aortic branches should be viewed with caution because manipulation either within a heavily calcified or atheromatous arch or within supra-aortic branches affected by atherosclerosis might be most likely to cause symptomatic central neurological injury. Treating patients with an aneurysmal formation on the basis of a remaining Type B aortic dissection after a previous Type A repair might represent an interesting option (provided that the alloplastic ascending replacement is at least 6.5 cm in length). Whether complete remodelling of downstream segments can be obtained by this approach or if additional classical surgical or endovascular procedures have to be added is dependent on known and less well-known mechanisms.
We regard classical surgery and orthotopic branched endovascular aortic arch repair as complementary rather than as competing procedures. The DB endovascular approach adds to the variety of options for treating aortic arch disease just as TAVI does in treating aortic valve stenosis in patients at high risk for classical surgery. This approach also translates to our daily practice because patients who would have been rejected or deemed high risk for classical surgery and who meet the anatomical criteria, now undergo this approach.
The need for reintervention in this series was low. However, the number of patients was also low, and the selection criteria for patients undergoing this approach are currently very strict. Higher patient numbers and longer follow-up times will help us to better understand the interaction of a nitinol frame with the highest elastic segment of the aorta, namely the ascending and the proximal arch as well as the proximal supra-aortic branches and their potential limitations.
Strengths and weaknesses
The approach is disruptive; however, the patient number and therefore the initial clinical experiences are limited. This new strategy to treat patients with thoracic aortic disease involving the aortic arch has the potential to enhance number of possible treatments, thereby providing a broader view of the underlying pathological characteristics of the disease and more personalized treatment options.
To summarize, orthotopic branched endovascular aortic arch repair using the Bolton Relay Plus DB endoprosthesis is a safe, feasible technique to treat patients with thoracic aortic disease who cannot undergo classical surgery. Aortic-related survival is excellent, and the occurrence of disabling stroke and endoleaks warranting treatment is low. Further studies are needed to assess the long-term durability of this new method.
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